Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00516893
Status:
COMPLETED
Last Update Posted:
2014-05-15
First Post:
2007-08-14
Brief Title:
Natalizumab High Titer Immunogenicity and Safety
Sponsor:
Biogen
Organization:
Biogen